Endothelial colony forming cells (ECFCs) are endowed with vascular regenerative ability.
ECFC immunogenicity and susceptibility to rejection is unknown.
We injected human ECFCs in the ischemic hindlimb of C57BL/6 J mice.
Treatment promotes blood flow recovery and endogenous production of angiogenic factors.